Cargando…
Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells.
There is considerable interest in immunohistochemical markers of proliferation which are suitable for use on routinely fixed clinical material. The novel proliferation-associated antibody Ki-S1 shows promise in this respect. In this study we have: (i) defined the pattern of Ki-S1 labelling relative...
Autores principales: | Camplejohn, R. S., Brock, A., Barnes, D. M., Gillett, C., Raikundalia, B., Kreipe, H., Parwaresch, M. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968331/ https://www.ncbi.nlm.nih.gov/pubmed/7682430 |
Ejemplares similares
-
The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre.
por: Camplejohn, R. S., et al.
Publicado: (1995) -
Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas.
por: Walker, R. A., et al.
Publicado: (1988) -
Flow Cytometric Detection of Proliferative Cells in Leukemias
por: Wakita, Atsushi, et al.
Publicado: (1994) -
Proliferative Index (Ki67) for Prediction in Breast Duct Carcinomas
por: Ahmed, Shatha Th, et al.
Publicado: (2018) -
Prognostic Value of Proliferation Markers: Immunohistochemical Ki-67 Expression and Cytometric S-Phase Fraction of Women with Breast Cancer in Libya
por: Ermiah, Eramah, et al.
Publicado: (2012)